Prostate Cancer Advance Could Improve Treatment Options, University of East Anglia Study

Published: Feb 13, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Findings published today in the British Journal of Cancer, and funded by the Association for International Cancer Research (AICR), show how a genetic mutation in untreated patients is linked to aggressive cancer later in life. It was previously thought that the mutation only occurred in response to therapy. The research highlights why relapses could occur in some men following hormone therapy. And it could help identify those patients that will develop fatal prostate cancer much earlier for life-extending therapy.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news